Trexquant Investment’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-207,649
Closed -$1.96M 2045
2026
Q1
$1.96M Sell
207,649
-22,868
-10% -$251K 0.01% 1007
2025
Q4
$2.86M Buy
+230,517
New +$3.06M 0.03% 841
2023
Q1
Sell
-8,866
Closed -$497K 1580
2022
Q4
$497K Sell
8,866
-49,095
-85% -$2.5M 0.01% 917
2022
Q3
$2.46M Buy
57,961
+38,884
+204% +$1.99M 0.09% 301
2022
Q2
$1.03M Buy
19,077
+6,075
+47% +$365K 0.05% 504
2022
Q1
$836K Buy
+13,002
New +$856K 0.04% 541
2020
Q3
Sell
-13,931
Closed -$655K 1356
2020
Q2
$655K Sell
13,931
-8,130
-37% -$400K 0.05% 562
2020
Q1
$985K Buy
+22,061
New +$1.16M 0.07% 422
2019
Q4
Sell
-10,602
Closed -$637K 1135
2019
Q3
$637K Buy
+10,602
New +$632K 0.06% 389
2019
Q1
Sell
-49,219
Closed -$2.22M 1123
2018
Q4
$2.22M Buy
49,219
+20,175
+69% +$1.11M 0.14% 216
2018
Q3
$1.91M Buy
+29,044
New +$1.8M 0.14% 212
2015
Q2
Sell
-18,593
Closed -$468K 1085
2015
Q1
$468K Sell
18,593
-3,181
-15% -$75.2K 0.05% 714
2014
Q4
$482K Buy
+21,774
New +$441K 0.09% 481

Other funds holding IART

Trexquant Investment's IART Position: Q2 2026 in Review

Trexquant Investment sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 207,649 shares — an estimated $1.96M sold.

Trexquant Investment first reported a position in IART in Q4 2014 and held it in 13 quarters. The position peaked at $2.86M in Q4 2025. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Trexquant Investment reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 207,649 Integra LifeSciences shares in Q2 2026, an estimated $1.96M.
  • Trexquant Investment first reported a position in Integra LifeSciences in Q4 2014 and held it in 13 quarters.
  • Trexquant Investment's Integra LifeSciences position peaked at $2.86M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.